Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 1 4Phase 3 2Phase 1/2 2

Status

Terminated 1Completed 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 104Colorectal Neoplasms 63Stomach Neoplasms 49Rectal Neoplasms 42Colonic Neoplasms 24Neoplasm Metastasis 21Nasopharyngeal Carcinoma 19Triple Negative Breast Neoplasms 18Pancreatic Neoplasms 14Parkinson Disease 4, Autosomal Dominant Lewy Body 12Neoplasms 12Gallbladder Neoplasms 7Cholangiocarcinoma 7Adenocarcinoma 6Esophageal Neoplasms 5Biliary Tract Neoplasms 5Adenocarcinoma Of Esophagus 5Esophageal Squamous Cell Carcinoma 4Neuroendocrine Tumors 3Gastrointestinal Neoplasms 3Digestive System Neoplasms 3Bile Duct Neoplasms 3Recurrence 2Pathologic Complete Response 2Liver Neoplasms 2Intestinal Neoplasms 2Hand-Foot Syndrome 2HER2-positive Advanced Breast Cancer 2HER2 Positive Metastatic Breast Cancer 2Drug-Related Side Effects and Adverse Reactions 2

Interventions

Sorafenib 8durvalumab 4Cisplatin 4Gemcitabine 3Ethiodized Oil 3Doxorubicin 3Chemotherapy, Adjuvant 3Bevacizumab 3tremelimumab 2sodium thiosulfate 2phosphomannopentaose sulfate 2Watchful Waiting 2Talaporfin 2Radiofrequency Ablation 2Oxaliplatin 2Nivolumab 2Folfox protocol 2Celecoxib 2Capecitabine 2Analgesia, Patient-Controlled 2seocalcitol 1parecoxib 1nolatrexed 1linifanib 1lenvatinib 1ferumoxides 1ferric carboxymaltose 1contrast agent BR1 1cabozantinib 1brivanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Liver Neoplasms × Capecitabine × Clear all
NCT00658593 2023-08-04

Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer

Canadian Cancer Trials Group

Phase 3 Terminated
19 enrolled
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

NCT00363584 2013-08-26

Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer

National Cancer Institute (NCI)

Phase 3 Completed
360 enrolled
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡